Cargando…
Eicosapentaenoic acid (EPA) efficacy for colorectal aberrant crypt foci (ACF): a double-blind randomized controlled trial
BACKGROUND: Colorectal cancer (CRC) is one of the most commonly occurring neoplasms and a leading cause of cancer death worldwide, and new preventive strategies are needed to lower the burden of this disease. Eicosapentaenoic acid (EPA), the omega-3 polyunsaturated fatty acid that is widely used in...
Autores principales: | Higurashi, Takuma, Hosono, Kunihiro, Endo, Hiroki, Takahashi, Hirokazu, Iida, Hiroshi, Uchiyama, Takashi, Ezuka, Akiko, Uchiyama, Shiori, Yamada, Eiji, Ohkubo, Hidenori, Sakai, Eiji, Maeda, Shin, Morita, Satoshi, Natsumeda, Yutaka, Nagase, Hajime, Nakajima, Atsushi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3515435/ https://www.ncbi.nlm.nih.gov/pubmed/22992267 http://dx.doi.org/10.1186/1471-2407-12-413 |
Ejemplares similares
-
Metformin efficacy and safety for colorectal polyps: a double-blind randomized controlled trial
por: Higurashi, Takuma, et al.
Publicado: (2012) -
Metallothionein crypt-restricted immunopositivity indices (MTCRII) correlate with aberrant crypt foci (ACF) in mouse colon
por: Donnelly, E T, et al.
Publicado: (2005) -
Rectal aberrant crypt foci (ACF) as a predictor of benign and malignant neoplastic lesions in the large intestine
por: Kowalczyk, Marek, et al.
Publicado: (2020) -
The efficacy of aspirin and metformin combination therapy in patients with rectal aberrant crypt foci: a double-blinded randomized controlled trial
por: Higurashi, Takuma, et al.
Publicado: (2020) -
The efficacy of a leukotriene receptor antagonist in the treatment of human rectal aberrant crypt foci: a nonrandomized, open-label, controlled trial
por: Higurashi, Takuma, et al.
Publicado: (2020)